<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04388748</url>
  </required_header>
  <id_info>
    <org_study_id>19-009475</org_study_id>
    <nct_id>NCT04388748</nct_id>
  </id_info>
  <brief_title>Stress Management and Resiliency Training for Depression vs Treatment as Usual in the Treatment of Major Depression</brief_title>
  <official_title>Randomized Controlled Trial of Stress Management and Resiliency Training for Depression (SMART-D) vs Treatment as Usual in the Treatment of Major Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to find out if a Stress Management and Resiliency Training (SMART-D)&#xD;
      therapy will help with major depression treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in patient health questionnaire depression assessment</measure>
    <time_frame>Baseline, week 1, week 8, 3 months, 6 months</time_frame>
    <description>Measured using the patient health questionnaire (PHQ-9) where total scores are reported on a scale of 1-4 Minimal depression, 5-9 Mild depression, 10-14 Moderate depression, 15-19 Moderately severe depression, 20-27 Severe depression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in severity of depression</measure>
    <time_frame>Baseline, week 1, week 8, 3 months, 6 months</time_frame>
    <description>Measured using the 17 item Hamilton Depression Rating scale (HAM-D) where total scores are reported on a scale of 0 - 7 = Normal, 8 - 13 = Mild Depression, 14-18 = Moderate Depression, 19 - 22 = Severe Depression, &gt; 23 = Very Severe Depression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in measures of resilience</measure>
    <time_frame>1 week, 8 week, 3 month, 6 month</time_frame>
    <description>Measured using the Connor Davidson Resiliency Scale. Subjects are asked to indicate if they agree with 25 statements on a scale of 0=not true at all, 1=rarely true, 2=sometimes true, 3=often true and 4=true nearly all the time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changed in perceived stress scale</measure>
    <time_frame>1 week, 8 week, 3 month, 6 month</time_frame>
    <description>Measured using Perceived Stress Scale (PSS). Subjects are asked to answer a 10 question about their feelings and thoughts during the last month using a scale of 0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Fairly Often, 4 = Very Often</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Major Depression</condition>
  <arm_group>
    <arm_group_label>SMART-D Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will participate in Stress Management and Resiliency Training for Depression (SMART-D) therapy as well as treatment as usual which consists of any ongoing medication or psychotherapy based treatments that are currently in place.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Treatment as usual will consist of any ongoing medication or psychotherapy based treatments that are currently in place.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress Management and Resiliency Training for Depression (SMART-D) Therapy</intervention_name>
    <description>6 SMART-D group therapy sessions over 8 weeks</description>
    <arm_group_label>SMART-D Intervention Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants will be enrolled for this study from patients attending the Mayo Clinic&#xD;
             Depression Center, Mayo Clinic Family Medicine clinics, Behavioral Health and Primary&#xD;
             Care Clinic at Mayo Clinic Health System, Austin, MN, with a diagnosis of major&#xD;
             depression, in partial or near remission with PHQ-9 scores â‰¤14&#xD;
&#xD;
          -  Participants will be required to be between 25 and 80 years old&#xD;
&#xD;
          -  Able to speak English&#xD;
&#xD;
          -  Able to provide written informed consent to participate in the study&#xD;
&#xD;
          -  Participants must have DSM-V diagnostic confirmation of major depressive disorder&#xD;
             (MDD) (American Psychiatric Association 2013).&#xD;
&#xD;
          -  Participants will continue taking any prescribed medications from their clinical&#xD;
             treatment team.&#xD;
&#xD;
          -  Participants with co-morbid secondary diagnoses of persistent depressive disorder and&#xD;
             generalized anxiety disorders will be included in the study.&#xD;
&#xD;
          -  Participants must consent to audio recording of random group sessions which will be&#xD;
             disclosed at the final study session.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants with bipolar disorder, active psychosis, active suicidal ideations, and&#xD;
             active substance abuse meeting criteria for substance use disorders except nicotine,&#xD;
             obsessive compulsive disorder, active panic disorder with agoraphobia or other phobic&#xD;
             disorder, active posttraumatic stress disorder, active severe personality disorders&#xD;
             will be excluded.&#xD;
&#xD;
          -  Pregnant women - because of time duration of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashok Seshadri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Harper</last_name>
    <phone>(507) 255-9352</phone>
    <email>harper.laura1@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic Health System in Albert Lea</name>
      <address>
        <city>Albert Lea</city>
        <state>Minnesota</state>
        <zip>56007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura N Harper</last_name>
      <phone>507-255-9352</phone>
      <email>harper.laura1@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Health System in Austin</name>
      <address>
        <city>Austin</city>
        <state>Minnesota</state>
        <zip>55912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura N Harper</last_name>
      <phone>507-255-9352</phone>
      <email>harper.laura1@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura N Harper</last_name>
      <phone>507-255-9352</phone>
      <email>harper.laura1@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 12, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2020</study_first_posted>
  <last_update_submitted>February 5, 2021</last_update_submitted>
  <last_update_submitted_qc>February 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Ashok Seshadri</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

